FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

21940211000001106: Insulin degludec (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2015. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    72651001000001118 Insulin degludec (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    72651101000001117 Insulin degludec en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Insulin degludec Is a Long-acting insulin false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Insulin degludec 100units/ml solution for injection 3ml cartridges Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Insulin degludec 100units/ml solution for injection 3ml pre-filled disposable devices Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Insulin degludec 200units/ml solution for injection 3ml pre-filled disposable devices Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Tresiba Penfill 100units/ml solution for injection 3ml cartridges (Novo Nordisk Ltd) Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Tresiba FlexTouch 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Tresiba FlexTouch 200units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Insulin degludec 200units/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Insulin degludec 100units/ml solution for injection 3ml pre-filled disposable devices 5 pre-filled disposable injection Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Insulin degludec 100units/ml solution for injection 3ml cartridges 5 cartridge Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Tresiba Penfill 100units/ml solution for injection 3ml cartridges (Novo Nordisk Ltd) 5 cartridge Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Tresiba FlexTouch 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) 5 pre-filled disposable injection Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Tresiba FlexTouch 200units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) 3 pre-filled disposable injection Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devices Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devices 5 pre-filled disposable injection Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier
    Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) 5 pre-filled disposable injection Has specific active ingredient False Insulin degludec Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start